TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
European Drug Testing Service EDTS AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
113,617
|
130,120
|
119,144 |
| Financial expenses |
81
|
107
|
130 |
| Earnings before taxes |
38,366
|
17,944
|
4,120 |
| EBITDA |
36,138
|
16,469
|
4,352 |
| Total assets |
143,654
|
108,228
|
90,653 |
| Current assets |
143,602
|
107,980
|
89,959 |
| Current liabilities |
27,255
|
25,752
|
27,775 |
| Equity capital |
112,814
|
81,005
|
62,421 |
| - share capital |
356
|
349
|
326 |
| Employees (average) |
28
|
27
|
27 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
78.5%
|
74.8%
|
68.9% |
| Turnover per employee |
4,058
|
4,819
|
4,413 |
| Profit as a percentage of turnover |
33.8%
|
13.8%
|
3.5% |
| Return on assets (ROA) |
26.8%
|
16.7%
|
4.7% |
| Current ratio |
526.9%
|
419.3%
|
323.9% |
| Return on equity (ROE) |
34.0%
|
22.2%
|
6.6% |
| Change turnover |
-18,849
|
2,521
|
17,063 |
| Change turnover % |
-14%
|
2%
|
17% |
| Chg. No. of employees |
1
|
0
|
-4 |
| Chg. No. of employees % |
4%
|
0%
|
-13% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.